| Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632) |
|---|
| 08/19/2004 | DE10305212A1 Verwendung der sgk-Genfamilie zur Diagnose und zur Therapie von Katarakt und Glaukom Use of the sgk gene family for the diagnosis and treatment of cataract and glaucoma |
| 08/19/2004 | DE10305050A1 Analytisches Testelement und Verfahren für Blutuntersuchungen Analytical test element and method for blood tests |
| 08/19/2004 | DE10304968A1 Vorrichtung und Verfahren zur Bestimmung und/oder Überwachung einer Prozessgröße eines Mediums Apparatus and method for determining and / or monitoring a process variable of a medium |
| 08/19/2004 | DE102004001188A1 Vorrichtung und Verfahren zum Bestimmen des Gesundheitsstatus eines Tieres Apparatus and method for determining the health status of an animal |
| 08/19/2004 | DE10146434B4 Vorrichtung zur Identifikation kontaminierter Behälter Apparatus for identification of contaminated containers |
| 08/19/2004 | DE10134183B4 Verfahren zum Typisieren von Textilien Method for typing textiles |
| 08/19/2004 | DE10036501B4 Verfahren zur Messung der JNK/SAPKs-Aktivität mittels der Bestimmung der Phosphorylierung von Transkriptionsfaktoren Method for measuring the JNK / SAPKs activity by determining the phosphorylation of transcription factors |
| 08/19/2004 | DE10006798B4 Verfahren zum Ermitteln eines biologischen Schadstoffabbaus in der Umwelt A method for detecting a biological contaminant degradation in the environment |
| 08/19/2004 | CA2804073A1 Method and apparatus for processing assay test results |
| 08/19/2004 | CA2519012A1 A method for the in vitro assessment of the progression status of an infection by an hiv virus in an individual |
| 08/19/2004 | CA2515347A1 Screening for modulators of fat storage |
| 08/19/2004 | CA2515339A1 Use of a novel polymorphism in the hsgk1 gene in the diagnosis of hypertonia and use of the sgk gene family in the diagnosis and therapy of the long qt syndrome |
| 08/19/2004 | CA2515148A1 Assay for protein isoforms |
| 08/19/2004 | CA2515144A1 Method for the detection of carbon monoxide in a hydrogen-rich gas stream |
| 08/19/2004 | CA2515135A1 Breast cancer-resistant protein inhibitor |
| 08/19/2004 | CA2515100A1 Trimeric polypeptide construct to induce an enduring t cell response |
| 08/19/2004 | CA2515084A1 Improved method of detection of hcv antibodies in combination assay or sole antibody assay |
| 08/19/2004 | CA2515081A1 Amphiregulin antibodies and their use to treat cancer and psoriasis |
| 08/19/2004 | CA2515001A1 Method and apparatus for processing assay test results |
| 08/19/2004 | CA2514942A1 Methods and compositions for the treatment of parkinson's disease and other a-synucleinopathies |
| 08/19/2004 | CA2514843A1 Protein fragment complementation assays for high-throughput and high-content screening |
| 08/19/2004 | CA2514841A1 Cell-killing molecules and methods of use thereof |
| 08/19/2004 | CA2514838A1 Nucleic acid antigens embedded in thermoplastic |
| 08/19/2004 | CA2514810A1 Use of islet 1 as a marker for isolating or generating stem cells |
| 08/19/2004 | CA2514743A1 Performance improvement for hematology analysis |
| 08/19/2004 | CA2514703A1 Use of the sgk gene family for diagnosis and therapy of cataracts and glaucoma |
| 08/19/2004 | CA2514576A1 Methods for treating, preventing and detecting helicobacter infection |
| 08/19/2004 | CA2514563A1 Inhibition of hiv-1 replication by disruption of the processing of the viral capsid-spacer peptide 1 protein |
| 08/19/2004 | CA2512624A1 Rat receptor tyrosine kinase, kdr |
| 08/19/2004 | CA2496017A1 Microreactor architecture and methods |
| 08/18/2004 | EP1447668A2 A method for improving data dependent ion selection in tandem mass spectroscopy of protein digests |
| 08/18/2004 | EP1447667A1 Test apparatus |
| 08/18/2004 | EP1447666A2 Biospecific binding reactants labeled with new luminescent lanthanide chelates and their use |
| 08/18/2004 | EP1447665A2 Method for reducing effect of hematocrit on measurement of an analyte in whole blood, and test kit and test article useful in the method |
| 08/18/2004 | EP1447664A2 Gas analysis apparatus and corresponding method |
| 08/18/2004 | EP1447662A1 Method of determining cationic surfactant |
| 08/18/2004 | EP1447660A1 Specific component concentration measuring method and concentration measuring instrument |
| 08/18/2004 | EP1447452A1 Method of detecting bias in enzyme electrode measurements |
| 08/18/2004 | EP1447448A1 Novel n-acetylglucosamine transferase, nucleic acid encoding the same, antibody against the same and use thereof for diagnosing cancer or tumor |
| 08/18/2004 | EP1447445A1 PROBE SOLUTIN COMPOSITIONS, REACTIVE CHIP USING THE SAME AND PROCESS FOR THE PRODUCTION THEREOF |
| 08/18/2004 | EP1447412A1 Method for the characterization of proteins, isolated proteins and uses therefore |
| 08/18/2004 | EP1447085A1 Agent controlling the production of osteoclast formation regulator and method of screening substance capable of controlling the production of osteoclast formation regulator |
| 08/18/2004 | EP1446757A2 In silico screening for phenotype-associated expressed sequences |
| 08/18/2004 | EP1446668A1 Device and method for treating magnetic particles |
| 08/18/2004 | EP1446667A2 Mass intensity profiling system and uses thereof |
| 08/18/2004 | EP1446666A1 Method for detecting analyte(s) using magnetic colloidal particles |
| 08/18/2004 | EP1446665A2 Isotopically coded affinity markers 3 |
| 08/18/2004 | EP1446664A1 Analyte detection system |
| 08/18/2004 | EP1446663A1 Rfid spoilage sensor for packaged food and drugs |
| 08/18/2004 | EP1446661A2 Sensor element and method for determining nitrogen oxides |
| 08/18/2004 | EP1446659A2 Systems and methods for the generation of crystalline polymorphs |
| 08/18/2004 | EP1446655A1 Fluid analyser systems |
| 08/18/2004 | EP1446651A2 A manifold device comprising a plurality of flow cells and fiber-optic probes for dissolution systems, and method |
| 08/18/2004 | EP1446634A1 Method for biomolecular sensing and system thereof |
| 08/18/2004 | EP1446507A2 Therapeutics and diagnostics for disorders of erythropoiesis |
| 08/18/2004 | EP1446506A2 COMPOSITIONS, METHODS AND KITS FOR DETERMINING THE PRESENCE OF i MYCOPLASMA PNEUMONIAE /i AND/OR i MYCOPLASMA GENITALIUM /i IN A TEST SAMPLE |
| 08/18/2004 | EP1446501A2 Methods for identification of cancer cell surface molecules and cancer specific promoters, and therapeutic uses thereof |
| 08/18/2004 | EP1446500A2 A method for regulating immune function in primates using the foxp3 protein |
| 08/18/2004 | EP1446498A2 Protease assay for therapeutic drug monitoring |
| 08/18/2004 | EP1446497A1 Methods of screening for toxicity of test compounds |
| 08/18/2004 | EP1446496A2 Methods for ligand dicovery |
| 08/18/2004 | EP1446495A2 Whole cell engineering using real-time metabolic flux analysis |
| 08/18/2004 | EP1446487A1 Mammalian protein phosphatases |
| 08/18/2004 | EP1446419A2 Therapeutic polypeptides, nucleic acids encoding the same, and methods of use |
| 08/18/2004 | EP1446416A1 Tumor specific monoclonal antibodies |
| 08/18/2004 | EP1446415A2 Detection and identification of enteric bacteria |
| 08/18/2004 | EP1446414A1 Differentially expressed genes associated with obesity and type 2 diabetes |
| 08/18/2004 | EP1446412A2 Novel lna compositions and uses thereof |
| 08/18/2004 | EP1446405A2 Inhibitors of cyclin-dependent kinases, compositions and uses related thereto |
| 08/18/2004 | EP1446387A1 Substituted aryl 1,4-pyrazine derivatives |
| 08/18/2004 | EP1446227A1 Device and method for preparing particles for analysis |
| 08/18/2004 | EP1446211A1 Size-exclusion filtering device, method for making same and resulting filtering method |
| 08/18/2004 | EP1446130A2 Ehrlichia canis genes and vaccines |
| 08/18/2004 | EP1446117A2 Treatment of acute myeloid leukemia with indolinone compounds |
| 08/18/2004 | EP1446044A2 Pin1 as a marker for prostate cancer |
| 08/18/2004 | EP1446008A2 Compositions and methods for controlled release |
| 08/18/2004 | EP1429603A4 Labeled cells for use as an internal functional control in rare cell detection assays |
| 08/18/2004 | EP1421386A4 High capacity assay platforms |
| 08/18/2004 | EP1407265A4 Colorimetric nanocrystal sensors, methods of making, and use thereof |
| 08/18/2004 | EP1405069A4 See through testing device |
| 08/18/2004 | EP1356078A4 Methods for diagnosing and treating pediatric neoplasms |
| 08/18/2004 | EP1350109A4 Marker for inflammatory conditions |
| 08/18/2004 | EP1325302A4 Active nems arrays for biochemical analyses |
| 08/18/2004 | EP1311487A4 Derivatives of 1,2-dihydro-7-hydroxyquinolines containing fused rings |
| 08/18/2004 | EP1305625A4 Method for immuno-detection of epitopes |
| 08/18/2004 | EP1299557A4 Signal amplification with lollipop probes |
| 08/18/2004 | EP1284929A4 Autocycle control of cooling water systems |
| 08/18/2004 | EP1261746A4 Method of monitoring hiv assembly and maturation |
| 08/18/2004 | EP1261724A4 Topoisomerase linker-mediated amplification methods |
| 08/18/2004 | EP1238125A4 Method of manufacture of colloidal rod particles as nanobar codes |
| 08/18/2004 | EP1227929A4 Colloidal rod particles as nanobar codes |
| 08/18/2004 | EP1200848A4 Quantum dots, semiconductor nanocrystals and semiconductor particles used as fluorescent coding elements |
| 08/18/2004 | EP1185705B1 Reverse transcriptase assay kit, use thereof and method for analysis of rt activity in biological samples |
| 08/18/2004 | EP1169641A4 Proteome mining |
| 08/18/2004 | EP1145012B1 Methods and kits for sequencing polypeptides |
| 08/18/2004 | EP1141691B1 Electrode system |
| 08/18/2004 | EP1129344B1 Methods and formulations for the separation of biological macromolecules |
| 08/18/2004 | EP1121457B1 Use of socs-2 or cis to screen for compounds enhancing growth hormone effect |
| 08/18/2004 | EP1098990A4 Blocked-polymerase polynucleotide immunoassay method and kit |
| 08/18/2004 | EP1064396A4 A selective assay for determining the identity of live microorganisms in a mixed culture |